DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Petitpretz P, Chidiac C, Soriano F. et al.
The efficacy and safety of oral pharmacokinetically enhanced
amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral
amoxycillin-clavulanate 1000/125 mg, three times daily, for the
treatment of bacterial community-acquired pneumonia in adults.
Int J Antimicrob Agents 2002; 20: 119-129 (1b)
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.